Correction to: Value of 2-[18F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review (Clinical and Translational Imaging, (2024), 12, 2, (187-195), 10.1007/s40336-024-00618-3)

Sambavy Nadaraja*, Jonas Helsing, Mohammad Naghavi-Behzad, Lotte H. Land, Christina H. Ruhlmann, Oke Gerke, Malene G. Hildebrandt

*Kontaktforfatter

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Abstract

In this article the author name Mohammad Naghavi-Behzad was incorrectly written as Mohammad Naghavi-Bezhad. The original article has been corrected.

OriginalsprogEngelsk
TidsskriftClinical and Translational Imaging
Vol/bind12
Udgave nummer3
Sider (fra-til)373
Antal sider1
ISSN2281-5872
DOI
StatusUdgivet - jun. 2024

Fingeraftryk

Dyk ned i forskningsemnerne om 'Correction to: Value of 2-[18F]FDG-PET/CT in identifying immune-related adverse events in patients with melanoma or non-small cell lung cancer: a systematic scoping review (Clinical and Translational Imaging, (2024), 12, 2, (187-195), 10.1007/s40336-024-00618-3)'. Sammen danner de et unikt fingeraftryk.

Citationsformater